
InfuSystem Holdings INFU
$ 8.61
-4.01%
Quarterly report 2025-Q3
added 11-04-2025
InfuSystem Holdings Total Shareholders Equity 2011-2026 | INFU
Annual Total Shareholders Equity InfuSystem Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 48 M | 48.3 M | 40.8 M | 22.3 M | 20.4 M | 31 M | 50.7 M | 50.3 M | 46.5 M | 42.7 M | 40 M | 40.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 50.7 M | 20.4 M | 40.1 M |
Quarterly Total Shareholders Equity InfuSystem Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.5 M | 54.5 M | 55.1 M | 57.5 M | 55.5 M | 53.5 M | 52.3 M | 52.3 M | 51.5 M | 50 M | 48.3 M | 48 M | 47.8 M | 46.5 M | 46.1 M | 48.3 M | 46.5 M | 44.7 M | 42.9 M | 40.8 M | 40.8 M | 40.8 M | 40.8 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 31 M | 31 M | 31 M | 31 M | 50.7 M | 50.7 M | 50.7 M | 50.7 M | 50.3 M | 50.3 M | 50.3 M | 50.3 M | 46.5 M | 46.5 M | 46.5 M | 46.5 M | 42.7 M | 42.7 M | 42.7 M | 42.7 M | 40 M | 40 M | 40 M | 40 M | 40.2 M | 40.2 M | 40.2 M | 40.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 57.5 M | 20.4 M | 42.3 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
Baxter International
BAX
|
6.96 B | $ 21.07 | 1.81 % | $ 10.7 B | ||
|
Becton, Dickinson and Company
BDX
|
25.4 B | $ 202.8 | -1.16 % | $ 58.3 B | ||
|
ICU Medical
ICUI
|
1.97 B | $ 151.86 | 0.14 % | $ 3.7 B | ||
|
iRhythm Technologies
IRTC
|
90.9 M | $ 180.4 | -4.68 % | $ 5.63 B | ||
|
Repro Med Systems
KRMD
|
20.4 M | $ 5.67 | -2.41 % | $ 259 M | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 140.04 | 1.54 % | $ 7.46 B | ||
|
Merit Medical Systems
MMSI
|
1.38 B | $ 86.37 | -7.31 % | $ 5.03 B | ||
|
Ekso Bionics Holdings
EKSO
|
12.7 M | $ 8.03 | -1.95 % | $ 162 M | ||
|
Alcon
ALC
|
18.8 B | $ 80.27 | -0.43 % | $ 40.4 B | ||
|
Predictive Oncology
POAI
|
-203 K | $ 6.83 | 1.08 % | $ 37.2 M | ||
|
AtriCure
ATRC
|
461 M | $ 41.66 | -1.76 % | $ 1.96 B | ||
|
electroCore
ECOR
|
7.44 M | $ 5.62 | 11.73 % | $ 31 K | ||
|
Haemonetics Corporation
HAE
|
821 M | $ 82.2 | -2.19 % | $ 4.14 B | ||
|
AngioDynamics
ANGO
|
183 M | $ 9.97 | -0.8 % | $ 407 M | ||
|
Harvard Bioscience
HBIO
|
73.1 M | $ 0.64 | -1.79 % | $ 27.1 M | ||
|
The Cooper Companies
COO
|
8.24 B | $ 83.71 | 0.69 % | $ 16.7 B | ||
|
LeMaitre Vascular
LMAT
|
337 M | $ 84.83 | -0.25 % | $ 1.9 B | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 113.09 | -0.93 % | $ 5.48 B | ||
|
Isoray
ISR
|
291 M | - | 0.03 % | $ 108 M | ||
|
Nephros
NEPH
|
8.36 M | $ 4.89 | -2.5 % | $ 50.8 M | ||
|
Utah Medical Products
UTMD
|
128 M | $ 59.83 | 1.87 % | $ 217 M | ||
|
Intuitive Surgical
ISRG
|
16.4 B | $ 587.18 | 0.36 % | $ 209 B | ||
|
Microbot Medical
MBOT
|
4.5 M | $ 2.08 | -5.02 % | $ 21.2 M | ||
|
Milestone Scientific
MLSS
|
5.83 M | $ 0.3 | 1.23 % | $ 23.9 M | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
2.93 B | $ 23.57 | -0.23 % | $ 4.06 B | ||
|
OraSure Technologies
OSUR
|
410 M | $ 2.63 | -1.13 % | $ 196 M | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 41.51 | 0.51 % | $ 136 M | ||
|
Pulse Biosciences
PLSE
|
44.4 M | $ 14.63 | -0.61 % | $ 703 M | ||
|
Repligen Corporation
RGEN
|
1.96 B | $ 166.85 | 0.26 % | $ 9.3 M | ||
|
ResMed
RMD
|
3.36 B | $ 252.15 | 0.49 % | $ 36.8 B | ||
|
BioLife Solutions
BLFS
|
349 M | $ 24.8 | -0.6 % | $ 1.14 B | ||
|
STERIS plc
STE
|
6.6 B | $ 258.0 | -1.03 % | $ 25.4 B | ||
|
Stereotaxis
STXS
|
16.3 M | $ 2.53 | -2.13 % | $ 204 M | ||
|
Retractable Technologies
RVP
|
87.2 M | $ 0.76 | -2.53 % | $ 22.8 M | ||
|
STAAR Surgical Company
STAA
|
397 M | $ 22.06 | -1.96 % | $ 1.08 B | ||
|
Teleflex Incorporated
TFX
|
4.28 B | $ 112.75 | 2.49 % | $ 5.28 B | ||
|
West Pharmaceutical Services
WST
|
2.68 B | $ 275.51 | 0.1 % | $ 20.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.94 B | $ 12.76 | 2.2 % | $ 2.59 B |